论文部分内容阅读
选择盆腔血瘀证已婚女性患者 10 5例 ,随机分为通瘀注射液治疗组及庆大霉素加地塞米松对照组 ,均采用非直观下输卵管盆腔给药 ,并对其进行疗效评估及机理研究。采用 30只实验性肠粘连大鼠随机分为通瘀组、庆大组及生理盐水对照组 ,探讨通瘀注射液的作用机理。结果表明 :通瘀注射液能改善盆腔血流 ,增加组织细胞供氧 ,降低血液粘度 ,增加机体非特异性免疫功能 ,从而控制炎症增生 ,促进粘连松解 ,具有活血化瘀 ,清热解毒 ,化瘀止痛等多方面功效
Select 105 patients with pelvic blood stasis syndrome married female patients, were randomly divided into Tongqi injection treatment group and gentamicin plus dexamethasone control group, all using non-intuitive fallopian tube pelvic administration, and its efficacy evaluation and Mechanism study. Thirty experimental intestinal adhesion rats were randomly divided into Tongqiao group, Qingda group and saline control group to explore the mechanism of Tongwei injection. The results showed that: Tongqiao injection can improve pelvic blood flow, increase oxygen supply to tissue cells, reduce blood viscosity, increase the body’s non-specific immune function, thereby controlling inflammatory hyperplasia, promote adhesion and release, with blood circulation, detoxification, and phlegm Various functions such as pain relief